Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • erikjlar
    Junior Member
    • Sep 2011
    • 3

    #16
    Thanks again for the input. I don't want to bother Cole with more questions - but maybe someone else can comment on alternative solutions if one just wants to do a simple gene-level summarization of reads.

    It seems to me that for this scenario, the sophistication of cufflinks can get in the way of getting a robust expression estimate (see my previous post and picture to see what I mean).

    Basically, for the example above I would be happy to just get FPKM values, or even read counts, based on all MYH11 exons - but excluding positions that ambiguously overlap with other genes.

    Someone must be doing this sort of "array-style" abundance estimates?

    Comment

    • dglemay
      Member
      • Feb 2011
      • 16

      #17
      gene-level estimates

      You could use the genes.fpkm_tracking files to get the FPKMs summarized at the gene level.

      Comment

      • Jon_Keats
        Senior Member
        • Mar 2010
        • 279

        #18
        Update

        I've had a chance to check my original dataset for the frequency of "FAIL" genes now with the newest version of Cufflinks. It is much improved with the number of FAIL genes now being between 73-238 compared to the previous version where the "FAIL" genes were between 8000-12,000 genes. There is still a trend for more "FAIL" genes as the number of aligned reads increases which I find odd but at this frequency it seems acceptable.
        Attached Files

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...